AMRX in the 13F filings
Amneal Pharmaceuticals Inc · CUSIP 03168L105
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 4 listed it in both
- Shares listed
- 15,427,768
- combined, among listed positions
- Reported value
- $265m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 11 buyers (opened or added shares) and 19 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,081,154.
Managers listing AMRX in Q2 2026
23 of 23 holders
Largest increases and reductions, by shares
Increases
- Citadel Advisors LLCexisting position · 1,118,715 shares now+541,296
- Balyasny Asset Management LLCexisting position · 434,132 shares now+355,009
- Invesco Ltdexisting position · 3,502,000 shares now+313,341
- Schonfeld Strategic Advisors LLCexisting position · 305,991 shares now+269,189
- Neuberger Berman Group LLCexisting position · 3,887,179 shares now+204,895
Reductions
- D. E. Shaw & Co.existing position · 774,055 shares now-945,899
- Millennium Management LLCexisting position · 14,761 shares now-354,972
- Acadian Asset Management LLCexisting position · 1,650,255 shares now-281,639
- Arrowstreet Capital LPexisting position · 334,758 shares now-189,209
- Renaissance Technologies LLCexisting position · 87,487 shares now-189,150
New positions and exits
New (0)
No new position among listed positions.
Exited (8)
- Voloridge Investment Management LLCwas $2.5m
- PDT Partners LLCwas $2.2m
- MFS Investment Managementwas $1.6m
- Caxton Associates LLPwas $1.0m
- Point72 Asset Management LPwas $971k
- Freestone Grove Partners LPwas $905k
- Man Group PLCwas $352k
- Hudson Bay Capital Management LPwas $149k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2018 | 3 | $226m | n.a. | n.a. |
| Q3 2018 | 6 | $588m | n.a. | n.a. |
| Q4 2018 | 3 | $514m | n.a. | n.a. |
| Q1 2019 | 3 | $514m | n.a. | n.a. |
| Q2 2019 | 1 | $24m | n.a. | n.a. |
| Q4 2020 | 1 | $2k | n.a. | n.a. |
| Q1 2021 | 3 | $30m | n.a. | n.a. |
| Q2 2021 | 2 | $9.3m | n.a. | n.a. |
| Q3 2021 | 2 | $20m | n.a. | n.a. |
| Q4 2021 | 2 | $16m | n.a. | n.a. |
| Q1 2022 | 2 | $13m | n.a. | n.a. |
| Q2 2022 | 1 | $11m | n.a. | n.a. |
| Q3 2023 | 2 | $879k | n.a. | n.a. |
| Q4 2023 | 1 | $506k | 0 | 1 |
| Q1 2024 | 2 | $4.7m | 2 | 0 |
| Q2 2024 | 2 | $13m | 2 | 1 |
| Q3 2024 | 3 | $23m | 3 | 0 |
| Q4 2024 | 2 | $14m | 2 | 1 |
| Q1 2025 | 4 | $39m | 4 | 0 |
| Q2 2025 | 3 | $28m | 2 | 1 |
| Q3 2025 | 4 | $37m | 2 | 2 |
| Q4 2025 | 5 | $85m | 17 | 14 |
| Q1 2026 | 7 | $78m | 14 | 19 |
| Q2 2026 | 4 | $101m | 11 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AMRX and LLY →AMRX and JNJ →AMRX and VRTX →Choose a stock to compare with AMRX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AMRX, latest filings →Back to the 13F Explorer →